N~3~-[3-(1H-INDOL-6-YL)BENZYL]PYRIDINE-2,3-DIAMINE

N~3~-[3-(1H-INDOL-6-YL)BENZYL]PYRIDINE-2,3-DIAMINE Uses, Dosage, Side Effects, Food Interaction and all others data.

Trade Name N~3~-[3-(1H-INDOL-6-YL)BENZYL]PYRIDINE-2,3-DIAMINE
Generic N~3~-[3-(1H-INDOL-6-YL)BENZYL]PYRIDINE-2,3-DIAMINE
Type
Formula C20H18N4
Weight Average: 314.3837
Monoisotopic: 314.153146596
Groups Experimental
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
N~3~-[3-(1H-INDOL-6-YL)BENZYL]PYRIDINE-2,3-DIAMINE
N~3~-[3-(1H-INDOL-6-YL)BENZYL]PYRIDINE-2,3-DIAMINE

Innovators Monograph

You find simplified version here N~3~-[3-(1H-INDOL-6-YL)BENZYL]PYRIDINE-2,3-DIAMINE



https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=11507920
https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?sid=99444464
https://www.chemspider.com/Chemical-Structure.9682717.html
http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=15785
https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/CHEMBL220896
https://zinc.docking.org/substances/ZINC000011525589
https://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/IP6
*** Taking medicines without doctor's advice can cause long-term problems.
Download Bissoy app from Play Store to get doctor's consultation over video call
Dr. Tanvir Rahman Shah

Dr. Tanvir Rahman

Psychiatrist

 Call Doctor
Dr. Zahidul Islam

Dr. Zahidul Islam

Child Specialist

 Call Doctor
Dr. Md. Mostofa Alam Bony

Dr. Md. Mostofa Alam Bony

Medicine Specialist

 Call Doctor
Dr. Khondoker Monirul Alam Russel

Dr. Khondoker Monirul Alam

Gastroenterologist

 Call Doctor
Dr. Sultana Ashrafi Ahmed

Dr. Sultana Ashrafi Ahmed

Kidney Specialist

Call Doctor
Dr. Md. Najmul Karim

Dr. Md. Najmul Karim

Hematologist

 Call Doctor
Dr. Redwana Hossain

Dr. Redwana Hossain

Psychiatrist

 Call Doctor
Dr. Md Waliur Rahman

Dr. Md Waliur Rahman

Child Specialist

 Call Doctor
Share

Related Content

N~3~-[5-(1H-INDOL-6-YL)-2-(PYRIDIN-2-YLMETHOXY)BENZYL]PYRIDINE-2,3-DIAMINE
5-(2-methylpiperazine-1-sulfonyl)isoquinoline
N-[2-(METHYLAMINO)ETHYL]-5-ISOQUINOLINESULFONAMIDE
{4-[(CARBOXYMETHOXY)CARBONYL]-3,3-DIOXIDO-1-OXONAPHTHO[1,2-D]ISOTHIAZOL-2(1H)-YL}ACETIC ACID
2-(CARBOXYMETHYL)-1-OXO-1,2-DIHYDRONAPHTHO[1,2-D]ISOTHIAZOLE-4-CARBOXYLIC ACID 3,3-DIOXIDE
5-(3-{3-[3-HYDROXY-2-(METHOXYCARBONYL)PHENOXY]PROPENYL}PHENYL)-4-(HYDROXYMETHYL)ISOXAZOLE-3-CARBOXYLIC ACID
ISOTHIAZOLIDINONE ANALOG
(2S)-2-{[3-(3-aminophenyl)imidazo[1,2-b]pyridazin-6-yl]amino}-3-methylbutan-1-ol
4-{[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino}-N-ethylpiperidine-1-carboxamide
N-anthracen-2-yl-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-amine
Abdominal x-ray
Lung needle biopsy
Hemoglobin electrophoresis
Necrobiosis lipoidica diabeticorum
Insulin in Blood
Alanine transaminase (ALT) blood test
Peritoneal fluid culture
Pleural fluid culture
Platelet aggregation test
CSF myelin basic protein
Creatinine Clearance 5-15 mL/min
Renal Tubular
Mild Hypertension
Metastatic disease has progressed within 12 months of neoadjuvant or adjuvant treatment with platinum-containing chemotherapy urothelial carcinoma (UC)
Severe Sustained ventricular tachycardia
Lumbar epidural anesthesia
Type III hyperlipidaemia
Infection Mixed
Electrolyte replacement
Transdermal contraception therapy